Natco Pharma launches generic blood cancer drug in India
The company has priced its generic medicine of POMALID 1 mg, 2 mg, and 4 mg capsules at an MRP Rs 5,000, Rs 10,000 and Rs 20,000…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Allow co-prescription of brands and generic: IDMA to PM
Says branded and generics markets can complement and supplement each other
US FDA makes eight observations at Lupin’s Aurangabad unit
The inspection was completed on April 26, 2017
Rajasthan Antibiotics to raise Rs 50 crore VC Funding
The funding would be pumped into company expansion through Greenfield and Brownfield
Torrent completes acquisition of Novartis brands
The two brands are widely prescribed by gynaecologists for the management of abnormal uterine bleeding, post menopausal symptoms…
VWR enters into definitive agreement with Avantor
The agreement will create a vertically integrated, global player in manufacturing and supply chain solutions for the life…
CPhI Worldwide Advisory Board inducts five new global experts
The board will help to steer the overall development of CPhI events and content
CPhI Worldwide, organised by UBM EMEA, has…
Hetero receives generic ‘Sofosbuvir+Velpatasvir’ approval from DCG(I)
The product will be marketed and distributed under the brand name ‘Velasof’ in India
Hester Biosciences net profit up by 29 per cent in Q4 FY17
The company has recommended final dividend of Rs 2.30 per share
Withdraw ‘TRIPS-plus’ proposals: MSF to Japan, S Korea
Response targets the 18th round of the RCEP trade talks, to be held in Manila this week